共 49 条
The (pro)renin receptor ((P)RR) can act as a repressor of Wnt signalling
被引:29
作者:
Bernhard, Sarah M.
[1
]
Seidel, Kerstin
[1
]
Schmitz, Jennifer
[1
]
Klare, Sabrina
[1
]
Kirsch, Sebastian
[1
]
Schrezenmeier, Eva
[1
]
Zaade, Daniela
[1
]
Meyborg, Heike
[2
]
Goldin-Lang, Petra
[2
]
Stawowy, Philipp
[2
]
Zollmann, Frank S.
[1
]
Unger, Thomas
[1
]
Funke-Kaiser, Heiko
[1
]
机构:
[1] Charite Univ Med Berlin, Inst Pharmacol, CCR, D-10115 Berlin, Germany
[2] Deutsch Herzzentrum Berlin DHZB, Dept Cardiol, Berlin, Germany
关键词:
(Pro)renin receptor;
Wnt;
Dvl;
Beta-catenin;
Furin;
Aliskiren;
VACUOLAR H+-ATPASE;
PRORENIN RECEPTOR;
NONPROTEOLYTIC ACTIVATION;
RENIN/PRORENIN RECEPTOR;
DIABETIC-NEPHROPATHY;
HANDLE-REGION;
RENIN;
PATHWAY;
ZEBRAFISH;
PROTEIN;
D O I:
10.1016/j.bcp.2012.09.020
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
The (pro)renin receptor ((P)RR) and Wnt signalling are both involved in different diseases ranging from cardiac and renal end-organ damage to cancer. (P)RR function involves signalling via the transcription factor promyelocytic leukemia zinc finger protein (PLZF) as well as the furin-mediated generation of vacuolar proton-translocating ATPase (V-ATPase)-associated and soluble (P)RR isoforms. Recently, the (P)RR was described as adaptor protein of Wnt (co)receptors. The aim of this study was to analyse the contribution of these distinct (P)RR functions to Wnt signalling. Using Tcf/Lef reporter gene systems in HEK293T and HepG2 cells and quantification of endogenous axin2 mRNA and protein levels in HEK293T cells we were able to demonstrate that full-length (P)RR acts as a repressor of Wnt signalling in a system preactivated either by Wnt3a stimulation or by constitutively active beta-catenin. These repressive effects are mediated by Dvl but are independent of the mutation status of beta-catenin. Furthermore, the V-ATPase complex, but not PLZF translocation or renin enzymatic activity, is necessary for the induction of Tcf/Lef-responsive genes by Wnt3a. Our data indicate interference of (P)RR and Wnt cascades, a fact that has to be considered concerning pathophysiology of cardio-renal and oncological entities as well as in drug development programs targeting (P)RR or Wnt pathways. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:1643 / 1650
页数:8
相关论文